Le Lézard
Classified in: Health, Science and technology, Business
Subject: CON

GreenSky Patient Solutions Signs Long-Term Consumer Credit Agreement With Essilor of America Adding Promotional Financing To The Annual Power of Vision Program


ATLANTA, March 28, 2017 /PRNewswire/ -- GreenSky Patient Solutions, LLC today announced a long-term agreement with Essilor of America to provide a consumer credit program to their network of Eye Care Professionals ("ECPs") throughout the United States.

"This new long-term partnership with Essilor of America, serves to offer more patients a convenient integrated financing payment option to enhance their vision and their lives by giving them access to Essilor's industry leading lens & optical technology," said Dennis Kelly, President of GreenSky Patient Solutions. "This agreement allows GreenSky to utilize our deep expertise in consumer credit, helping solidify a leadership position in the healthcare consumer financing market." 

Essilor of America is the leading manufacturer of optical lenses in the United States and is the market leader in progressive, high-index, photochromic and anti-reflective coated lenses.  GreenSky Patient Solutions, LLC, is a wholly owned subsidiary of GreenSky, LLC, which is one of the leading financial technology companies in the country.  It provides innovative technology-enabled payment solutions that power its partners to generate more sales and enhance loyalty amongst their patients.

In 2017, the popular Power of Vision program will offer for the first time, "no interest" promotional financing for up to six months1 for qualifying patients who purchase any of Essilor's premium lenses -- Varilux®, Crizal®, Transitions®, Xperio UVtm and Eyezentm.  Along with financing, patients will be eligible to receive $10 per qualifying product with a maximum of $30 per pair of glasses. The Power of Vision program is only available through independent ECPs and will be supported by Essilor's national advertising campaigns including television and online media, which will encourage consumers to find an independent ECP through an exclusive online locator tool.

Enrollment for ECPs began on February 13, 2017, and the Power Of Vision promotion offering financing coupled with rebates will be made available to consumers beginning April 1.  For more information or to enroll, please visit PowerofVision.com.

About GreenSky Patient Solutions, LLC
GreenSky Patient Solutions, LLC, is a wholly owned subsidiary of GreenSky, LLC, which is one of the leading financial technology companies in the country.  It provides technology-enabled payment solutions that power our partners to generate more sales and create loyal customers. The GreenSky® Program has helped more than 14,000 merchants and healthcare providers nationwide provide fast, frictionless and easy financing options. The GreenSky Patient Solutionstm Program is operated on behalf of, and financing is provided by, federally-insured, federal and state chartered financial institutions.  GreenSky® is based in Atlanta, Georgia. More information can be found at www.GreenSky.com. GreenSky® is a registered trademark of GreenSky, LLC.

1 Subject to qualifying credit approval.  Payments are required during the 6 month promotional period. Making minimum monthly payments during the promotional period will not pay off the entire purchase balance. Interest accrues at 29.99% during the promotional period, but all interest is waived if the purchase balance is paid in full before the expiration of the 6 month promotional period.  Financing for the GreenSky Patient Solutionstm Program is provided by federally insured, federal and state chartered banks providing credit without regard to age, race, color, religion, national origin, sex or familial status.

 

SOURCE GreenSky Patient Solutions, LLC


These press releases may also interest you

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

23 avr 2024
Astellas Pharma Inc....



News published on and distributed by: